NASDAQ:CYMI - Cymer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cymer logoCymer, Inc. (Cymer) is a supplier of light sources used in the photolithography process for semiconductor, or chip manufacturing. The Company provides light sources designed to help enable the performance of wafer steppers and wafer scanners built by lithography tool manufacturers. The Company operates in two segments: light source products and display products. It provides installed base products in support of its chipmaker customers, who use its light sources in their advanced wafer patterning production processes. The Company's TCZ segment develops, integrates, markets and supports silicon crystallization tools used in the manufacture of different types of displays, including low temperature poly-silicon liquid crystal displays (LTPS - LCD) and organic light emitting diode (OLED) displays. In May 2013, Cymer Inc completed the previously announced merger pursuant to which ASML Holding NV acquired Cymer.

Receive CYMI News and Ratings via Email

Sign-up to receive the latest news and ratings for CYMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustrySemiconductor Equipment
SectorN/A
SymbolNASDAQ:CYMI
CUSIP23257210
Phone+1-858-3857300

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

The Truth About Cryptocurrencies

Cymer (NASDAQ:CYMI) Frequently Asked Questions

What is Cymer's stock symbol?

Cymer trades on the NASDAQ under the ticker symbol "CYMI."

What is the consensus analysts' recommendation for Cymer?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cymer in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Cymer been receiving favorable news coverage?

News stories about CYMI stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cymer earned a news sentiment score of 0.13 on Accern's scale. They also gave press coverage about the semiconductor company an impact score of 46.34 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Cymer?

Shares of CYMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Cymer?

Cymer's mailing address is 17075 Thornmint Ct., SAN DIEGO, CA 92127, United States. The semiconductor company can be reached via phone at +1-858-3857300.


MarketBeat Community Rating for Cymer (NASDAQ CYMI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  165
MarketBeat's community ratings are surveys of what our community members think about Cymer and other stocks. Vote "Outperform" if you believe CYMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.